Bluetooth-enabled insulin pen is world's first

German diabetes specialist Emperra has launched the first wireless insulin pen that transfers data to a patient’s blood glucose diary via Bluetooth. The CE-marked device is launching in Germany with an eye toward an FDA approval in 2016.

The pen, called Esysta, gives patients and doctors the ability to map out blood glucose levels and dosing regimens in real time either in person or from remote locations without multiple connections.

The pen can be used by patients with either Type 1 or Type 2 diabetes.

“The smart insulin pen and corresponding software appeal to patients and doctors who prefer state-of-the-art technical solutions and who have recognized that the digitalization of diabetes management is a simple and reliable solution,” Emperra CEO Christian Krey said in a release.

- here's the release

Related Articles:
J&J rolls out wearable insulin patch data in advance of 2016 launch
Novo Nordisk new insulin pen to stimulate U.S. demand


Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.